Pinnacle Financial Partners (Tennessee)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$523K Buy
12,111
+667
+6% +$26.1K 0.01% 334
2025
Q2
$439K Buy
11,444
+509
+5% +$19.4K 0.01% 354
2025
Q1
$424K Buy
10,935
+172
+2% +$6.3K 0.01% 347
2024
Q4
$364K Hold
10,763
0.01% 358
2024
Q3
$440K Hold
10,763
0.01% 336
2024
Q2
$414K Sell
10,763
-4,909
-31% -$206K 0.01% 340
2024
Q1
$672K Buy
15,672
+3,940
+34% +$162K 0.01% 299
2023
Q4
$435K Buy
11,732
+592
+5% +$21.3K 0.01% 320
2023
Q3
$404K Sell
11,140
-188
-2% -$6.67K 0.01% 313
2023
Q2
$404K Buy
11,328
+245
+2% +$8.79K 0.01% 315
2023
Q1
$394K Hold
11,083
0.01% 320
2022
Q4
$389K Buy
11,083
+11,047
+30,686% +$368K 0.01% 312
2022
Q3
$1K Sell
36
-10,930
-100% -$414K ﹤0.01% 528
2022
Q2
$597K Hold
10,966
0.02% 258
2022
Q1
$597K Hold
10,966
0.02% 265
2021
Q4
$604K Hold
10,966
0.02% 272
2021
Q3
$524K Hold
10,966
0.02% 270
2021
Q2
$546K Hold
10,966
0.02% 262
2021
Q1
$489K Sell
10,966
-368
-3% -$16.7K 0.02% 256
2020
Q4
$521K Sell
11,334
-559
-5% -$25.7K 0.03% 246
2020
Q3
$560K Sell
11,893
-117
-1% -$5.86K 0.03% 230
2020
Q2
$612K Sell
12,010
-405
-3% -$20.8K 0.03% 226
2020
Q1
$588K Sell
12,415
-79
-0.6% -$4.21K 0.04% 221
2019
Q4
$734K Buy
12,494
+40
+0.3% +$2.23K 0.05% 232
2019
Q3
$664K Sell
12,454
-188
-1% -$9.67K 0.05% 225
2019
Q2
$632K Sell
12,642
-88
-0.7% -$4.42K 0.05% 221
2019
Q1
$665K Sell
12,730
-129
-1% -$6.45K 0.05% 214
2018
Q4
$614K Sell
12,859
-461
-3% -$22.7K 0.06% 209
2018
Q3
$669K Sell
13,320
-22
-0.2% -$1.12K 0.06% 217
2018
Q2
$672K Buy
13,342
+860
+7% +$43.3K 0.06% 202
2018
Q1
$610K Buy
12,482
+32
+0.3% +$1.49K 0.06% 198
2017
Q4
$552K Buy
12,450
+2,420
+24% +$112K 0.06% 201
2017
Q3
$509K Hold
10,030
0.07% 186
2017
Q2
$541K Buy
+10,030
New +$535K 0.08% 200
2014
Q3
Sell
-3,800
Closed -$254K 204
2014
Q2
$254K Hold
3,800
0.1% 158
2014
Q1
$254K Sell
3,800
-2,414
-39% -$163K 0.11% 146
2013
Q4
$415K Buy
+6,214
New +$403K 0.19% 115

Other funds holding GSK

Pinnacle Financial Partners (Tennessee)'s GSK Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) increased its GSK (GSK) stake by 5.8% in Q3 2025, buying an estimated $26.1K and bringing the position to 12,111 shares worth $523K. The position accounts for 0.01% of the portfolio, ranked #334.

Pinnacle Financial Partners (Tennessee) first reported a position in GSK in Q4 2013 and has held it in 37 quarters since. The position peaked at $734K in Q4 2019. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Pinnacle Financial Partners (Tennessee) held 12,111 shares of GSK worth $523K as of Q3 2025.
  • Pinnacle Financial Partners (Tennessee) bought 667 GSK shares in Q3 2025, an estimated $26.1K.
  • GSK made up 0.01% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #334 holding.
  • Pinnacle Financial Partners (Tennessee) first reported a position in GSK in Q4 2013 and has held it in 37 quarters since.
  • Pinnacle Financial Partners (Tennessee)'s GSK position peaked at $734K in Q4 2019.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.